Moliterno AR - Search Results

1

Human-induced pluripotent stem cells from blood cells of healthy donors and patients with acquired blood disorders.

Ye Z, Zhan H, Mali P, Dowey S, Williams DM, Jang YY, Dang CV, Spivak JL, Moliterno AR, Cheng L. Ye Z, et al. Among authors: moliterno ar. Blood. 2009 Dec 24;114(27):5473-80. doi: 10.1182/blood-2009-04-217406. Epub 2009 Oct 1. Blood. 2009. PMID: 19797525 Free PMC article.

2

Anemia of cancer.

Moliterno AR, Spivak JL. Moliterno AR, et al. Hematol Oncol Clin North Am. 1996 Apr;10(2):345-63. doi: 10.1016/s0889-8588(05)70342-7. Hematol Oncol Clin North Am. 1996. PMID: 8707759 Free article. Review.

3

Impaired expression of the thrombopoietin receptor by platelets from patients with polycythemia vera.

Moliterno AR, Hankins WD, Spivak JL. Moliterno AR, et al. N Engl J Med. 1998 Feb 26;338(9):572-80. doi: 10.1056/NEJM199802263380903. N Engl J Med. 1998. PMID: 9475764 Free article.

4

Posttranslational processing of the thrombopoietin receptor is impaired in polycythemia vera.

Moliterno AR, Spivak JL. Moliterno AR, et al. Blood. 1999 Oct 15;94(8):2555-61. Blood. 1999. PMID: 10515857 Free article.

5

A novel thrombopoietin signaling defect in polycythemia vera platelets.

Moliterno AR, Siebel KE, Sun AY, Hankins WD, Spivak JL. Moliterno AR, et al. Stem Cells. 1998;16 Suppl 2:185-92. doi: 10.1002/stem.5530160721. Stem Cells. 1998. PMID: 11012190

6

Mpl Baltimore: a thrombopoietin receptor polymorphism associated with thrombocytosis.

Moliterno AR, Williams DM, Gutierrez-Alamillo LI, Salvatori R, Ingersoll RG, Spivak JL. Moliterno AR, et al. Proc Natl Acad Sci U S A. 2004 Aug 3;101(31):11444-7. doi: 10.1073/pnas.0404241101. Epub 2004 Jul 21. Proc Natl Acad Sci U S A. 2004. PMID: 15269348 Free PMC article.

7

Wasted sheep and premature infants: the role of trace metals in hematopoiesis.

Mullally AM, Vogelsang GB, Moliterno AR. Mullally AM, et al. Among authors: moliterno ar. Blood Rev. 2004 Dec;18(4):227-34. doi: 10.1016/S0268-960X(03)00067-5. Blood Rev. 2004. PMID: 15501551 Review.

8

Molecular mimicry in the chronic myeloproliferative disorders: reciprocity between quantitative JAK2 V617F and Mpl expression.

Moliterno AR, Williams DM, Rogers O, Spivak JL. Moliterno AR, et al. Blood. 2006 Dec 1;108(12):3913-5. doi: 10.1182/blood-2006-03-008805. Epub 2006 Aug 15. Blood. 2006. PMID: 16912229 Free PMC article. Clinical Trial.

9

Case 15-2006: the Budd-Chiari syndrome and V617F mutation in JAK2.

Spivak JL, Moliterno AR, Silver RT. Spivak JL, et al. Among authors: moliterno ar. N Engl J Med. 2006 Aug 17;355(7):737; author reply 738. doi: 10.1056/NEJMc061631. N Engl J Med. 2006. PMID: 16914715 No abstract available.

10

The quantitative JAK2 V617F neutrophil allele burden does not correlate with thrombotic risk in essential thrombocytosis.

Pemmaraju N, Moliterno AR, Williams DM, Rogers O, Spivak JL. Pemmaraju N, et al. Among authors: moliterno ar. Leukemia. 2007 Oct;21(10):2210-2. doi: 10.1038/sj.leu.2404755. Epub 2007 May 17. Leukemia. 2007. PMID: 17507997 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

88 results

Search Page

Filters